✦ LIBER ✦

Essential thrombocythemia: A clonal disorder of hematopoietic stem cell

✍ Scribed by Usha Singal; Dr. Ananda S. Prasad; David M. Halton; Carter Bishop

Book ID: 101432701
Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 500 KB
Volume: 14
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830140212

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Essential thrombocythemias without V617F

Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders

✍ Kiladjian, J-J; Elkassar, N; Cassinat, B; Hetet, G; Giraudier, S; Balitrand, N; 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

Hematopoietic stem cell transplantation-

Hematopoietic stem cell transplantation-associated thrombotic microangiopathy: defining a disorder

✍ George, J N 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 86 KB

Persisting multilineage transgene expres

Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell

✍ Li, Z; Fehse, B; Schiedlmeier, B; Düllmann, J; Frank, O; Zander, A R; Ostertag, 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 272 KB

The return of clonal marking sheds new l

The return of clonal marking sheds new light on human hematopoietic stem cells

✍ Lemischka, Ihor R.; Jordan, Craig T. 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB

Proteomic analysis of hematopoietic stem

Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders

✍ Ota, Jun; Yamashita, Yoshihiro; Okawa, Katsuya; Kisanuki, Hiroyuki; Fujiwara, Sh 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 220 KB

P110 Defect of JAK2/STAT5 signalling pat

P110 Defect of JAK2/STAT5 signalling pathway in essential thrombocythemia and myelofibrosis. (Hypothesis: Malignant Stem Cell transformation)

✍ E. Gulya; P. Gombás; A. Kárpáti; K. Kristó; A. Matolcsy; Z. Mátrai; K. Pecze 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 52 KB

bicytopenia (anemia and thrombocytopenia). She is again transfusion dependent and on H1 and H2 blockers. Conclusion: Cladribine therapy is efficient in patient with systemic mastocytosis but response is transient so there is need for new therapy options in this rare hematologic disease. P110 Defect